研究“根据DECAF评分筛选适合家庭治疗的慢性阻塞性肺疾病加重期患者:一项非劣性、随机对照研究和经济学评价”(Home treatment of COPD exacerbation selected by DECAF score:a non-inferiority,randomised controlled trial and econ...研究“根据DECAF评分筛选适合家庭治疗的慢性阻塞性肺疾病加重期患者:一项非劣性、随机对照研究和经济学评价”(Home treatment of COPD exacerbation selected by DECAF score:a non-inferiority,randomised controlled trial and economic evaluation).作者Echevarria C,Gray J,Hartley T,Miller J,Simpson AJ,Gibson GJ,Bourke SC.发表于Thorax 2018;73:713-722。该项目资金来自英国国家健康研究所——患者福利研究计划(National Institute for Health Research-Research for Patient Benefit Programme)(项目编号PB-PG-0213-30105)。NIHR signal全文阅读,请登陆网址:https://discover,dc.nihr.ac.uk/content/signal-000691/hospital-at-home-treatment-for-copd-flare-ups.(编者注:NIHR,全称National Institute for Health Research,是英国一个旨在通过科学研究来提高国家的卫生健康的机构,详见网站<https://www.nihr.ac.uk/).展开更多
文摘研究“根据DECAF评分筛选适合家庭治疗的慢性阻塞性肺疾病加重期患者:一项非劣性、随机对照研究和经济学评价”(Home treatment of COPD exacerbation selected by DECAF score:a non-inferiority,randomised controlled trial and economic evaluation).作者Echevarria C,Gray J,Hartley T,Miller J,Simpson AJ,Gibson GJ,Bourke SC.发表于Thorax 2018;73:713-722。该项目资金来自英国国家健康研究所——患者福利研究计划(National Institute for Health Research-Research for Patient Benefit Programme)(项目编号PB-PG-0213-30105)。NIHR signal全文阅读,请登陆网址:https://discover,dc.nihr.ac.uk/content/signal-000691/hospital-at-home-treatment-for-copd-flare-ups.(编者注:NIHR,全称National Institute for Health Research,是英国一个旨在通过科学研究来提高国家的卫生健康的机构,详见网站<https://www.nihr.ac.uk/).
